Product
Luteinizing Hormone-Releasing Hormone Agonists
1 clinical trial
1 indication
Indication
Ovarian CancerClinical trial
A Phase II, Open-Label, Multicenter, Platform Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian TumorsStatus: Active (not recruiting), Estimated PCD: 2028-05-30